Hammond JC, Lahti AC, Kraguljac NV. Rapid clozapine titration in an acutely agitated patient with schizoaffective disorder: a case report. Journal of Clinical Psychopharmacology. In press
Money KM, Olah Z, Korade Z, Garbett KA, Shelton RC.  An altered peripheral IL6 response in major depressive disorder. Neurobiology of Disease (in press).

Singh JB, Fedgchin M, Daly EJ, De Boer P, Cooper K, Lim P, Pinter C, Murrough JW, Sanacora G, Shelton RC, Kurian B, Winokur A, Fava M, Manji H, Drevets WC, Nueten LV. A double-blind, randomized, placebo-controlled, dose-frequency study of intravenous ketamine in adult patients with treatment-resistant depression. Am J Psychiatry (in press).
Shelton RC, Pencina MJ, Barrentine LW, Ruiz JA, Fava M, Zajecka JM, Papakostas GI. Association of obesity and inflammatory marker levels on treatment outcome from a double-blind, randomized study of adjunctive l-methylfolate calcium (Deplin) in MDD Patients who are inadequate responders to SSRIs. J Clin Psychiatry 76:1635–1641, 2015
Reid MA, White DM, Kraguljac NV, Lahti AC. A combined diffusion tensor imaging and magnetic resonance spectroscopy study of patients with schizophrenia. Schizophrenia Research, In press
Kraguljac NV, White DM, Hadley N, Hadley JA, Lawrence VH, Davis E, Lahti AC. Aberrant hippocampal connectivity in unmedicated patients with schizophrenia and effects of antipsychotic medication: A longitudinal resting state functional MRI study. Schizophrenia Bulletin, In press
Kraguljac NV, White DM, Hadley JA, Visscher KM, Knight DC, Ver Hoef LW, Falola B, Lahti AC. Abnormalities in large scale functional networks in unmedicated patients with schizophrenia and effects of risperidone. NeuroImage: Clinical, in press.
McCollum LA, RE McCullumsmith, RC Roberts. Tyrosine hydroxylase localization in the nucleus accumbens in schizophrenia. Brain Structure and Function, In Press.

Bhambhvani HP, Simmons M, Haroutunian V, and Meador-Woodruff JH: Decreased Expression of Cortactin in Schizophrenia Brain. NeuroReport. In press.
Lahti AC. Making progress towards individualized medicine in the treatment of psychosis. The American Journal of Psychiatry. In Press